Display options
Share it on

Cancer Prev Res (Phila). 2011 Apr;4(4):481-5. doi: 10.1158/1940-6207.CAPR-10-0358.

Stress influences on anoikis.

Cancer prevention research (Philadelphia, Pa.)

Anil K Sood, Susan K Lutgendorf

Affiliations

  1. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. [email protected]

PMID: 21464029 PMCID: PMC3074235 DOI: 10.1158/1940-6207.CAPR-10-0358

Abstract

It long has been suspected that psychosocial factors affect cancer development and progression. Although the connections between stress and cancer causation are not strong, epidemiologic and clinical studies have provided strong links between cancer progression and several stress-related factors including chronic stress, depression, and social isolation. Recent molecular and biological studies have identified specific signaling pathways that influence cancer growth and metastasis. In particular, stress hormones can have a significant impact on protecting cancer cells from undergoing the anoikis form of programmed cell death, thus, providing a mechanistic advantage for metastasis. This review provides an overview of the relationship between psychosocial factors and the avoidance of anoikis by cancer cells.

©2011 AACR.

References

  1. J Psychosom Res. 2004 Oct;57(4):353-8 - PubMed
  2. J Cell Biochem. 2007 Jul 1;101(4):927-36 - PubMed
  3. Differentiation. 2002 Dec;70(9-10):498-505 - PubMed
  4. Psychol Rev. 2005 Apr;112(2):417-45 - PubMed
  5. Endocrinology. 1996 Dec;137(12):5597-604 - PubMed
  6. Brain Behav Immun. 2009 Feb;23(2):176-83 - PubMed
  7. Oncotarget. 2010 Nov;1(7):628-38 - PubMed
  8. J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):230-1 - PubMed
  9. Int J Cancer. 2003 Dec 20;107(6):1023-9 - PubMed
  10. J Biol Chem. 2010 Nov 12;285(46):35462-70 - PubMed
  11. Brain Behav Immun. 2005 Mar;19(2):91-103 - PubMed
  12. Cell. 1992 Dec 11;71(6):891-4 - PubMed
  13. BMJ. 1999 Oct 16;319(7216):1027-30 - PubMed
  14. Endocrine. 1998 Jun;8(3):309-15 - PubMed
  15. Cancer Res. 2006 Nov 1;66(21):10357-64 - PubMed
  16. Biochem Soc Trans. 2004 Jun;32(Pt3):421-5 - PubMed
  17. Cancer Causes Control. 2004 Aug;15(6):535-41 - PubMed
  18. Nat Clin Pract Oncol. 2008 Aug;5(8):466-75 - PubMed
  19. Oncogene. 1998 May;16(20):2681-6 - PubMed
  20. Nat Rev Cancer. 2006 Mar;6(3):240-8 - PubMed
  21. Apoptosis. 2002 Jun;7(3):247-60 - PubMed
  22. Pathol Int. 2000 Apr;50(4):273-9 - PubMed
  23. Am J Pathol. 2004 Oct;165(4):1087-95 - PubMed
  24. J Clin Invest. 2010 May;120(5):1515-23 - PubMed
  25. J Natl Cancer Inst. 1998 Jan 7;90(1):30-6 - PubMed
  26. Neurochem Res. 1987 Apr;12(4):393-7 - PubMed
  27. Am J Epidemiol. 2003 Mar 1;157(5):415-23 - PubMed
  28. J Psychosom Res. 2004 Jan;56(1):1-8 - PubMed
  29. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4280-5 - PubMed
  30. Brain Behav Immun. 2011 Feb;25(2):250-5 - PubMed
  31. J Biol Chem. 2007 Oct 12;282(41):29919-26 - PubMed
  32. Br J Cancer. 2000 Dec;83(11):1448-53 - PubMed
  33. Nat Med. 2006 Aug;12(8):939-44 - PubMed
  34. BMJ. 1995 Dec 9;311(7019):1527-30 - PubMed
  35. Psychol Med. 2007 Jun;37(6):863-71 - PubMed
  36. Science. 1977 Apr 8;196(4286):129-36 - PubMed
  37. Cancer Prev Res (Phila). 2009 Oct;2(10):850-861 - PubMed
  38. N Engl J Med. 1998 Jan 15;338(3):171-9 - PubMed
  39. J Clin Oncol. 2005 Oct 1;23(28):7105-13 - PubMed
  40. Nat Rev Endocrinol. 2009 Jul;5(7):374-81 - PubMed
  41. Am J Cardiol. 1970 Sep;26(3):289-99 - PubMed
  42. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5 - PubMed
  43. Ann N Y Acad Sci. 2000;917:29-37 - PubMed
  44. Microsc Res Tech. 2002 Dec 15;59(6):495-502 - PubMed
  45. Cancer. 2008 Dec 15;113(12):3450-8 - PubMed
  46. Endocrine. 2001 Jul;15(2):187-92 - PubMed

MeSH terms

Publication Types

Grant support